Product Information

NICOTINE 4 MG MINI LOZENGE is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3711 per EA under NDC 45802095702. Its NADAC has been published 535 times since Aug 17, 2016.

FDA first approved this application on Oct 9, 2012.

NICOTINE 4 MG MINI LOZENGE

Nicotine Polacrilex
$0.3711per EA
OTC

Strength

4 mg/1

NDC

45802095702

Classification

Generic

Dosage Form

LOZENGE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

NICOTINE

Approval Type

Generic (ANDA)

FDA Application

ANDA203690

FDA Approved

10/9/2012

On Market Since

7/8/2016

Pharmacological Classes

Price Statistics

The NADAC for NICOTINE 4 MG MINI LOZENGE has been published 535 times since Aug 17, 2016, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3711 per EA
All-time high$0.4244 (Oct 11, 2017)
All-time low$0.3337 (May 22, 2024)
52-week high$0.3906
52-week low$0.3568
Median price$0.3680
Average price$0.3691
Largest weekly change+17.9% (Sep 20, 2017)
Weeks tracked535
Tracking sinceAug 17, 2016

Price History

1W

0.0%

1M

-4.5%

3M

-3.2%

6M

+2.7%

1Y

+3.4%

3Y

+5.3%

5Y

+4.4%

All

+4.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NICOTINE 4 MG MINI LOZENGE?

The current National Average Drug Acquisition Cost (NADAC) for NICOTINE 4 MG MINI LOZENGE, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3711 per EA (NDC 45802095702), effective Nov 11, 2026.

How has the price of NICOTINE 4 MG MINI LOZENGE changed over time?

Over the history we have for it, the NADAC for NICOTINE 4 MG MINI LOZENGE has risen 4.7%. It has been tracked across 535 weekly CMS publications since Aug 17, 2016.

What are the highest and lowest recorded NADAC prices for NICOTINE 4 MG MINI LOZENGE?

Since Aug 17, 2016, the NADAC for NICOTINE 4 MG MINI LOZENGE has ranged from a low of $0.3337 (May 22, 2024) to a high of $0.4244 (Oct 11, 2017), with a median of $0.3680 per EA.

Are there cheaper alternatives to NICOTINE 4 MG MINI LOZENGE?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NICOTINE 4 MG LOZENGE, is $0.3459 per EA — about 7% below NICOTINE 4 MG MINI LOZENGE.

Who manufactures NICOTINE 4 MG MINI LOZENGE?

NICOTINE 4 MG MINI LOZENGE (NDC 45802095702) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.